Carboxyalkylether-acat inhibitor combinations

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/255 (2006.01) A61K 31/194 (2006.01) A61P 3/06 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2413906

The invention is a pharmaceutical composition comprising a carboxyalkylether which lowers triglycerides and LDL and elevates HDL, and an ACAT inhibitor which improves dyslipidemias in mammals, said composition being useful for treating dyslipidemia and ischemic syndromes, and for preventing or delaying the onset of heart attacks. The carboxyalkylethers have the formula (I) wherein Y1 and Y2 include COOH, R1, R2, R3, and R4 can be alkyl, and n and m are integers from 2 to 9; and the ACAT inhibitors have the formula (IV) where R is hydrogen, X is O, R1 and R2 are substituted phenyl, and Y is alkylene.

L'invention porte sur une préparation pharmaceutique comportant: un carboxyalkyléther qui abaisse le niveau des triglycérides et du LDL et augmente celui du HDL; et un inhibiteur de l'ACAT améliorant les dyslipidémies chez les mammifères, ladite préparation s'avère donc utile pour traiter les dyslipidémies et les syndromes ischémiques, et prévenir ou retarder l'apparition des crises cardiaques. Lesdits carboxyalkyléthers présentent la formule (I) dans laquelle: Y¿1? et Y¿2? comportent COOH, R¿1?, R¿2?, R¿3?, et R¿4? peuvent être alkyle, et n et m sont des entiers de 2 à 9, tandis que les inhibiteurs de l'ACAT présentent la formule (II) dans laquelle: R est H, X est O, R¿1? et R¿2? sont phényle substitué, et Y est alkylène.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Carboxyalkylether-acat inhibitor combinations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carboxyalkylether-acat inhibitor combinations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxyalkylether-acat inhibitor combinations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1971390

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.